JPS58190392A - 宿主−ベクタ−系における宿主として有用な枯草菌の無胞子性変異株 - Google Patents

宿主−ベクタ−系における宿主として有用な枯草菌の無胞子性変異株

Info

Publication number: JPS58190392A
Authority: JP; Japan
Prior art keywords: host; strain; spore; cells; dna
Prior art date: 1982-04-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP58069281A

Other languages

English (en)

Japanese (ja)

Inventor

ドナルド・エイチ・デイ−ン

ダニエル・エム・エリス

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Unilever Bestfoods North America

Original Assignee

Unilever Bestfoods North America

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-21

Filing date

1983-04-21

Publication date

1983-11-07

1983-04-21 Application filed by Unilever Bestfoods North America filed Critical Unilever Bestfoods North America

1983-11-07 Publication of JPS58190392A publication Critical patent/JPS58190392A/ja

Status Pending legal-status Critical Current

Links

239000013598 vector Substances 0.000 title claims description 13
241000894006 Bacteria Species 0.000 claims description 9
230000002068 genetic effect Effects 0.000 claims description 8
244000063299 Bacillus subtilis Species 0.000 claims description 2
235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
244000025254 Cannabis sativa Species 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 25
210000004027 cell Anatomy 0.000 description 22
108020004414 DNA Proteins 0.000 description 16
244000005700 microbiome Species 0.000 description 16
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 15
239000002609 medium Substances 0.000 description 12
238000000034 method Methods 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
239000013612 plasmid Substances 0.000 description 10
238000012360 testing method Methods 0.000 description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
108020004511 Recombinant DNA Proteins 0.000 description 6
239000000243 solution Substances 0.000 description 6
230000009466 transformation Effects 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 5
239000003550 marker Substances 0.000 description 5
239000000203 mixture Substances 0.000 description 5
229940113082 thymine Drugs 0.000 description 5
230000035899 viability Effects 0.000 description 5
229920001817 Agar Polymers 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
239000008272 agar Substances 0.000 description 4
230000035772 mutation Effects 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000008103 glucose Substances 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
239000012071 phase Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
150000003230 pyrimidines Chemical class 0.000 description 3
238000012216 screening Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
230000026683 transduction Effects 0.000 description 3
238000010361 transduction Methods 0.000 description 3
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
108020004638 Circular DNA Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
238000004448 titration Methods 0.000 description 2
IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 2
229960001082 trimethoprim Drugs 0.000 description 2
NQEQTYPJSIEPHW-MNOVXSKESA-N (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate Chemical compound C1=CC=C2C([C@H](O)[C@@H](COP(O)(O)=O)O)=CNC2=C1 NQEQTYPJSIEPHW-MNOVXSKESA-N 0.000 description 1
ZYHIULSBMGTPBF-UHFFFAOYSA-N 1-(3-aminopropyl)-3-(2,6-dimethylphenyl)urea Chemical compound Cc1cccc(C)c1NC(=O)NCCCN ZYHIULSBMGTPBF-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
240000006439 Aspergillus oryzae Species 0.000 description 1
235000002247 Aspergillus oryzae Nutrition 0.000 description 1
241000304886 Bacilli Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
241001669680 Dormitator maculatus Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
241000406668 Loxodonta cyclotis Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
101100454869 Rattus norvegicus Lhx5 gene Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
101150052863 THY1 gene Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
239000002253 acid Substances 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
230000030414 genetic transfer Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
230000036438 mutation frequency Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
230000002623 sporogenic effect Effects 0.000 description 1
230000028070 sporulation Effects 0.000 description 1
230000037351 starvation Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000007704 transition Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
239000004474 valine Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
- Y10S435/839—Bacillus subtilis

Landscapes

Genetics & Genomics (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

JP58069281A 1982-04-21 1983-04-21 宿主−ベクタ−系における宿主として有用な枯草菌の無胞子性変異株 Pending JPS58190392A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/370,239 US4450236A (en)	1982-04-21	1982-04-21	Asporogenic mutant of Bacillus subtilis useful as a host in a host-vector system
US370239		1982-04-21

Publications (1)

Publication Number	Publication Date
JPS58190392A true JPS58190392A (ja)	1983-11-07

Family

ID=23458816

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP58069281A Pending JPS58190392A (ja)	1982-04-21	1983-04-21	宿主−ベクタ−系における宿主として有用な枯草菌の無胞子性変異株

Country Status (12)

Country	Link
US (1)	US4450236A (fr)
EP (1)	EP0092233A3 (fr)
JP (1)	JPS58190392A (fr)
AU (1)	AU555542B2 (fr)
CA (1)	CA1191101A (fr)
DK (1)	DK173483A (fr)
GB (1)	GB2120678B (fr)
HK (1)	HK84285A (fr)
IE (1)	IE54750B1 (fr)
IL (1)	IL68379A (fr)
SG (1)	SG67185G (fr)
ZA (1)	ZA832454B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1193564A (fr) *	1982-07-09	1985-09-17	University Of Western Ontario	Mutants de microorganismes contenant des toxines utilises dans la lutte contre les insectes
IE58099B1 (en) *	1984-06-06	1993-06-30	Cpc International Inc	Amylase-negative, asporogenous mutant of bacillus subtilis useful as a host in a host-vector system
US4828994A (en) *	1984-09-21	1989-05-09	Genex Corporation	Bacillus strains with reduced extracellular protease levels
IT1244477B (it) *	1990-12-21	1994-07-15	Eniricerche Spa	Ceppo asporigeno di bacillus subtilis e suo impiego come ospite per la preparazione di prodotti eterologhi
US8673290B2 (en)	2011-03-01	2014-03-18	MYGALAXY Limited Company	Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4237224A (en) *	1974-11-04	1980-12-02	Board Of Trustees Of The Leland Stanford Jr. University	Process for producing biologically functional molecular chimeras
US4302544A (en) *	1979-10-15	1981-11-24	University Of Rochester	Asporogenous mutant of B. subtilis for use as host component of HV1 system

1982
- 1982-04-21 US US06/370,239 patent/US4450236A/en not_active Expired - Fee Related
1983
- 1983-03-30 IE IE719/83A patent/IE54750B1/en unknown
- 1983-04-07 ZA ZA832454A patent/ZA832454B/xx unknown
- 1983-04-07 AU AU13223/83A patent/AU555542B2/en not_active Ceased
- 1983-04-14 IL IL68379A patent/IL68379A/xx unknown
- 1983-04-19 EP EP83103779A patent/EP0092233A3/fr not_active Withdrawn
- 1983-04-20 CA CA000426253A patent/CA1191101A/fr not_active Expired
- 1983-04-20 GB GB08310741A patent/GB2120678B/en not_active Expired
- 1983-04-20 DK DK173483A patent/DK173483A/da active IP Right Grant
- 1983-04-21 JP JP58069281A patent/JPS58190392A/ja active Pending
1985
- 1985-09-10 SG SG671/85A patent/SG67185G/en unknown
- 1985-10-31 HK HK842/85A patent/HK84285A/xx unknown

Also Published As

Publication number	Publication date
EP0092233A3 (fr)	1984-09-12
CA1191101A (fr)	1985-07-30
AU555542B2 (en)	1986-10-02
IL68379A0 (en)	1983-07-31
IE54750B1 (en)	1990-01-31
GB2120678A (en)	1983-12-07
IL68379A (en)	1986-02-28
US4450236A (en)	1984-05-22
EP0092233A2 (fr)	1983-10-26
DK173483D0 (da)	1983-04-20
DK173483A (da)	1983-10-22
GB2120678B (en)	1985-07-31
HK84285A (en)	1985-11-08
ZA832454B (en)	1983-12-28
SG67185G (en)	1988-09-30
IE830719L (en)	1983-10-21
GB8310741D0 (en)	1983-05-25
AU1322383A (en)	1983-10-27

Publication	Publication Date	Title
US4450235A (en)	1984-05-22	Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system
Lederberg et al.	1958	Protoplasts and L-type growth of Escherichia coli
Shikano et al.	1990	Changes of traits in a bacterial population associated with protozoal predation
JPS6038114B2 (ja)	1985-08-30	プラスミドｄｎａの遺伝子産物の製法
PL153465B1 (en)	1991-04-30	Pesticide
Suzuki et al.	1981	Role of the flaR gene in flagellar hook formation in Salmonella spp
Reynolds et al.	1978	Identification of the binding protein which may be the target of penicillin action in Bacillus megaterium
JPS5998692A (ja)	1984-06-07	アグロバクテリウムのｔ−ｄｎａを利用して緑藻類中への外部遺伝子導入方法
Mahoney et al.	1966	Fine structure of Thiobacillus thiooxidans
Ko et al.	1994	Dynamic clustering of bacterial population
JPS58190392A (ja)	1983-11-07	宿主−ベクタ−系における宿主として有用な枯草菌の無胞子性変異株
US4465773A (en)	1984-08-14	Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system
Dienes	1953	Some new observations on L forms of bacteria
Apirion et al.	1967	The loss of phenotypic suppression in streptomycin-resistant mutants.
JPS59130187A (ja)	1984-07-26	バチルス微生物における遺伝子の異型クロ−ニング方法
Bott et al.	1977	Characterization of glutamine requiring mutants of Bacillus subtilis
US4690897A (en)	1987-09-01	Method for transformation of anaerobic microorganisms
Shimada et al.	1987	Effect of alternating current exposure on the resistivity of resting Escherichia coli B cells to crystal violet and other basic dyes
Shanahan et al.	1948	Further studies on the morphology of Escherichia coli exposed to penicillin
Green	1969	Genetic transfer in Pseudomonas aeruginosa
Dienes	1970	Permanent alterations of the L-forms of Proteus and Salmonella under various conditions
Boudreaux	1978	Biochemical Studies on Growth and Sporulation in Bacillus Cereus Strain T.
CN118562677A (zh)	2024-08-30	光合西塞菌新物种及其应用
Gonzalez et al.	1984	Effect of uracil on colonial morphology of Neisseria gonorrhoeae
JP2005253462A (ja)	2005-09-22	レシピエント細胞の形質転換方法